Africa Holguin | Microbiology | Best Researcher Award

Published on by Academic Achievements

Dr. Africa Holguin | Microbiology | Best Researcher Award

Dr. Africa Holguin | Microbiology – Investigador at Instituto Ramón y Cajal de Investigación Sanitaria – IRYCIS, Spain

Dr. Africa Holguín is a globally respected virologist and the Head of the HIV-1 Molecular Epidemiology Laboratory at IRYCIS – Hospital Ramón y Cajal in Madrid, Spain. Her work has significantly advanced the global understanding of HIV genetic variability, antiretroviral resistance, and viral surveillance. She has been a leading figure in molecular virology research for over two decades and is especially recognized for her studies on non-B HIV-1 subtypes, viral quasispecies, and the epidemiological patterns of drug resistance mutations. With over 5,300 citations and more than 100 publications, Dr. Holguín is a key contributor to the global HIV research community and a scientific leader in infectious disease molecular diagnostics.

Academic Profile:

ORCID

Scopus

Google Scholar

Education:

Dr. Holguín completed her graduate studies in biological sciences with a specialization in virology and molecular biology. Her academic training emphasized molecular diagnostics and viral genomics, providing her with the tools to engage in complex viral surveillance projects. She later deepened her specialization in infectious diseases through advanced research training, equipping her to lead cross-disciplinary studies on the molecular epidemiology of HIV and other RNA viruses.

Experience:

With over 25 years of experience in clinical virology and molecular epidemiology, Dr. Holguín has led numerous high-impact national and international research projects. Her role as the head of a specialized research laboratory has allowed her to supervise a range of HIV-related studies, including drug resistance surveillance, viral genetic analysis, and epidemiological modeling. She collaborates with global health bodies and research consortia and has worked extensively on patient cohorts including immigrants, children, and treatment-naïve populations. She also provides expert input for public health decision-making and clinical guideline development.

Research Interests:

Dr. Holguín’s research focuses on the molecular evolution of HIV-1, especially non-B subtypes, and how natural genetic polymorphisms affect treatment outcomes. She investigates antiretroviral resistance, viral quasispecies, and genetic recombination events that impact diagnosis and therapy. Her interests extend to real-world applications, such as viral load testing accuracy and genotype interpretation systems. Recently, she has contributed to molecular surveillance of SARS-CoV-2, showcasing her adaptability and leadership in emerging infectious disease research.

Awards:

Dr. Holguín has received multiple accolades and recognitions for her contributions to virology and public health. Her work has influenced global HIV treatment strategies, and she has participated in advisory panels and policy-shaping discussions at the national and international level. She has also received institutional recognition for her mentorship and leadership in scientific research and has played a key role in developing Spain’s HIV molecular monitoring infrastructure.

Selected Publications 📚:

  1. 📘 “Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review” – The Lancet Infectious Diseases, 2019 – Cited by 457
  2. 📗 “Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype” – PLoS Medicine, 2005 – Cited by 393
  3. 📙 “Pol gene quasispecies of HIV: mutations associated with drug resistance in untreated patients” – Journal of Virology, 1995 – Cited by 274
  4. 🧬 “Evolution of SARS-CoV-2 structural proteins from the start of the pandemic to September 2020” – Viruses, 2021 – Cited by 113
  5. 📒 “High prevalence of HIV-1 subtype G and natural polymorphisms among immigrants in Madrid” – AIDS, 2002 – Cited by 98
  6. 📕 “Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis in immigrant sex workers in Spain” – Journal of Medical Virology, 2004 – Cited by 83
  7. 📓 “Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes” – AIDS Reviews, 2006 – Cited by 81

Conclusion:

Dr. Africa Holguín’s remarkable research record, impactful collaborations, and long-term leadership in the field of HIV molecular epidemiology make her a strong candidate for the Best Researcher Award. Her commitment to scientific excellence, especially in the areas of viral resistance and subtype diversity, has contributed to meaningful advancements in clinical care and global health policy. With a strong citation record, consistent publication output, and a multidisciplinary approach to emerging infectious diseases, Dr. Holguín exemplifies the qualities of an outstanding researcher whose work continues to shape the future of virology and public health.

 

 

Ziyong Liu | microbiology | Best Researcher Award

Published on by Academic Achievements

Dr. Ziyong Liu | microbiology | Best Researcher Award

Dr. Ziyong Liu | microbiology – Qingdao Institute Of Bioenergy & Bioprocess Technology Chinese Academy Of Sciences, China

Dr. Ziyong Liu is a renowned researcher in the field of bioenergy and microbiology. With a strong focus on microbial fermentation and metabolic regulation, his research has contributed significantly to understanding microbial processes, particularly in the production of biofuels. Throughout his career, he has explored the metabolic pathways of various Clostridium species, which are central to biotechnological applications aimed at sustainable energy solutions. His scientific expertise, alongside his collaborative work with researchers worldwide, has positioned him as a key figure in the study of microbial systems and bioengineering.

Profile:

Orcid

Education:

Dr. Liu pursued his higher education at the Technical University of Munich, where he obtained his Doctoral degree in microbiology. His doctoral research laid the foundation for his future work in microbial fermentation and metabolic regulation. The knowledge and skills gained during this period allowed him to address crucial challenges in bioenergy production and provided a solid grounding in laboratory-based research, data analysis, and innovative problem-solving in the field of microbiology.

Experience:

Dr. Liu is currently based at the Qingdao Institute of Bioenergy and Bioprocess Technology, where he applies his expertise to solve real-world problems in bioenergy production. His professional journey has seen him working in various research capacities, contributing to groundbreaking projects focused on metabolic engineering and microbial processes. Dr. Liu’s collaborative work spans across several international research projects, allowing him to develop solutions with global implications for bioenergy and sustainability. His professional experience has made him a vital member of the research community, dedicated to advancing bioengineering practices in both academia and industry.

Research Interests:

Dr. Liu’s primary research interests lie in microbial metabolism, fermentation processes, and bioenergy. His work focuses on optimizing microbial strains for enhanced biofuel production, with particular attention to Clostridium species such as Clostridium ljungdahlii, Clostridium cellulovorans, and Clostridium beijerinckii. These microorganisms have been identified as key players in converting biomass and carbon dioxide into valuable biofuels and chemicals. His research explores the intricate mechanisms of metabolic regulation, fermentation efficiency, and strain improvement to improve the yield and sustainability of biofuels. Dr. Liu’s studies contribute to addressing the global energy crisis and advancing the field of renewable energy.

Awards:

Dr. Liu’s exceptional contributions to bioenergy research have earned him recognition within the scientific community. His groundbreaking work on metabolic regulation and microbial fermentation processes has been widely acknowledged. Although specific awards were not detailed, his continued involvement in high-impact publications and international collaborations reflects his standing as a leading researcher in his field. His ongoing contribution to solving pressing energy challenges positions him as a deserving candidate for the “Best Researcher Award.”

Publications:

  1. “pH-Dependent Metabolic Regulation in Clostridium ljungdahlii During CO Fermentation” (2025) – Fermentation
    A detailed study on the metabolic regulation of Clostridium ljungdahlii under varying pH conditions, contributing to the understanding of CO fermentation processes.
    💡 Cited by: Multiple studies on metabolic engineering and biofuel production.
  2. “Metabolic Difference Analysis of Clostridium cellulovorans Grown on Glucose and Cellulose” (2023) – Fermentation
    Analyzes the metabolic pathways of Clostridium cellulovorans, focusing on its growth on glucose and cellulose. This work highlights its potential for biomass conversion.
    🔬 Cited by: Research on microbial fermentation and biomass utilization.
  3. “Butanol–Isopropanol Fermentation with Oxygen-Tolerant Clostridium beijerinckii XH29” (2022) – AMB Express
    A study on improving fermentation processes with oxygen-tolerant strains of Clostridium beijerinckii, aiming at efficient biofuel production.
    ⚡ Cited by: Articles on biofuel production and oxygen-tolerant fermentation.

Conclusion:

Dr. Ziyong Liu has made exceptional strides in the field of bioenergy and microbiology, contributing to the understanding of microbial metabolic regulation and its application in biofuel production. His research into Clostridium species has paved the way for advances in sustainable energy solutions, addressing global challenges in biofuel efficiency and sustainability. With a career marked by impactful publications and collaborative research efforts, Dr. Liu stands out as a highly valuable member of the scientific community. His achievements, coupled with his potential for future innovations, make him a strong candidate for the “Best Researcher Award.”

Ibrar Khan | Microbiology | Best Researcher Award

Published on by Academic Achievements

Dr. Ibrar Khan | Microbiology | Best Researcher Award

Assistant Professor at Abbottabad University of Science and Technology, Pakistan

 Dr. Ibrar Khan is a dedicated microbiologist and academician specializing in applied microbiology, biological control, and bioremediation. With extensive research experience, he has contributed significantly to microbial biotechnology, environmental microbiology, and industrial microbiology. Currently serving as an Assistant Professor at Abbottabad University of Science and Technology (AUST), Pakistan, Dr. Khan continues to inspire students and researchers through his innovative work in microbiology.

Profile

Google scholar

Education🎓 

Dr. Ibrar Khan holds a Ph.D. in Microbiology from Ocean University of China (2012-2015), where he focused on microbial biotechnology and bioremediation. He also earned an M.Phil. in Microbiology from Quaid-I-Azam University, Islamabad (2010-2012), and a BS (Hons) in Microbiology from Hazara University, Mansehra, Pakistan (2005-2009). His academic journey reflects his commitment to excellence in microbiological research.

Experience🏋️ 

As an Assistant Professor at AUST since 2016, Dr. Khan has been involved in teaching and research in microbiology. Previously, he served as an Assistant Professor at Hazara University, Mansehra, and as a Junior Research Assistant at Quaid-I-Azam University. He has also worked as a microbiologist at Ayub Teaching Hospital, gaining practical experience in clinical microbiology. His extensive teaching and research experience have enabled him to mentor numerous postgraduate students.

Research Interest📝

Dr. Khan’s research focuses on applied microbiology, bioremediation, phage therapy, and metabolic engineering. His work addresses biological control of bacterial diseases, environmental pollution degradation, biomolecule production, and industrial microbiology. His contributions have led to advancements in microbial technology for sustainable solutions in agriculture and environmental management.

Awards & Grants🏆

Dr. Khan’s achievements include a Gold Medal for his BS (Hons) in Microbiology, a Merit Scholarship for his M.Phil., and a Ph.D. Scholarship under the China Scholarship Council (CSC). He has also received several research grants, such as the NRPU Project for bacteriophage-based control of rice bacterial blight and the ORIC-AUST grant for developing essential oil-based disinfectants for COVID-19.

Publications📃

Dr. Khan has published extensively in high-impact journals. Some notable publications include:

“Microbial biosynthesis and secretion of l-malic acid and its applications”
Cited by: 172
Year: 2016

“Mycoremediation of heavy metal (Cd and Cr)–polluted soil through indigenous metallotolerant fungal isolates”
Cited by: 151
Year: 2019

“A review on remediation technologies for heavy metals contaminated soil”
Cited by: 106
Year: 2020

“An overview of the plant-mediated synthesis of zinc oxide nanoparticles and their antimicrobial potential”
Cited by: 88
Year: 2020

“Mycoremediation: a treatment for heavy metal-polluted soil using indigenous metallotolerant fungi”
Cited by: 68
Year: 2019

“Medicinal plants: a repository of antiviral metabolites”
Cited by: 66
Year: 2017

“Extraction and screening of bioactive compounds with antimicrobial properties from selected species of mollusk and crustacean”
Cited by: 63
Year: 2014

“Calcium malate overproduction by Penicillium viticola 152 using the medium containing corn steep liquor”
Cited by: 60
Year: 2014

“Microbes and environment: global warming reverting the frozen zombies”
Cited by: 54
Year: 2020

“Myogenesis and analysis of antimicrobial potential of silver nanoparticles (AgNPs) against pathogenic bacteria”
Cited by: 52
Year: 2023

“Chaetomium endophytes: a repository of pharmacologically active metabolites”
Cited by: 52
Year: 2016

“CRISPR/Cas system: a game-changing genome editing technology, to treat human genetic diseases”
Cited by: 47
Year: 2019

“Isolation and Characterization of Heavy Metal Resistant Fungal Isolates from Industrial Soil in China”
Cited by: 38
Year: 2016

“High-level production of calcium malate from glucose by Penicillium sclerotiorum K302”
Cited by: 37
Year: 2013

“Endophytic fungi associated with Taxus fuana (West Himalayan Yew) of Pakistan: potential bio-resources for cancer chemopreventive agents”
Cited by: 32
Year: 2016

“Prevalence and Association of Obesity with Self‐Reported Comorbidity: A Cross‐Sectional Study of 1321 Adult Participants in Lasbela, Balochistan”
Cited by: 26
Year: 2017

 

Conclusion🌟

Dr. Ibrar Khan is a highly qualified researcher with a strong academic and research profile, making him a strong candidate for the Best Researcher Award. His contributions to applied microbiology, environmental bioremediation, and phage therapy are notable. With further advancements in high-impact publications, international collaborations, and patent development, he can further solidify his standing as a leading researcher in microbiology.

Dr. Fizza Khalid | Microbiology Award | Best Researcher Award

Published on by Academic Achievements

Dr. Fizza Khalid | Microbiology Award | Best Researcher Award 

Dr. Fizza Khalid, Dr Sulaiman Al-Habib Medical Diagnostic Laboratory, Saudi Arabia

Fizza Khalid is a dedicated Microbiologist with a robust educational background and extensive experience in laboratory research and clinical analysis. She holds a Ph.D. in Medical Microbiology from the University of Health Sciences in Lahore, where her research focused on the characterization of drug-resistant Acinetobacter baumannii strains. With a solid foundation in both M.Phil. and M.Sc. degrees in Medical Microbiology and Medical Technology, respectively, Fizza has developed expertise in microbial resistance and quality control in clinical settings. Currently serving as the Deputy Head of the Clinical Research Committee and Specialized Lab Supervisor at MD LAB, Dr. Sulaiman AlHabib Medical Group in Saudi Arabia, she excels in collaborative research, training healthcare professionals, and ensuring compliance with regulatory standards. Fizza is committed to advancing microbiological science and improving patient outcomes through her meticulous approach and passion for research, making her a valuable asset to any healthcare organization.

Professional Profile:

ORCID 

Summary of Suitability for Best Researcher Award:

Dr. Fizza Khalid is an exemplary candidate for the Best Researcher Award, distinguished by her extensive educational background and significant contributions to the field of microbiology. With a Ph.D. in Medical Microbiology from the University of Health Sciences, her research has primarily focused on the characterization of drug-resistant strains of Acinetobacter baumannii, a critical issue in healthcare today.

Education:

  • Ph.D. in Medical Microbiology
    University of Health Sciences, Lahore (2016–2023)
    Thesis: Characterization of locally isolated Acinetobacter baumannii strains for drug resistance and biofilm formation.
  • M. Phil in Medical Microbiology
    University of Health Sciences, Lahore (2012–2014)
    Thesis: In-vitro efficacy of Polymyxin B with Rifampin, Colistin, and Doxycycline against extensively drug-resistant Acinetobacter baumannii.
  • M.Sc. in Medical Technology
    University of Health Sciences, Lahore (2008–2010)
    Thesis: Frequency of extended spectrum beta-lactamase enzymes in the clinical isolate of Salmonella typhi.
  • B.Sc. in Medical Laboratory Technology
    University of the Health Sciences, Lahore (2005–2007).

Work Experience:

  • Deputy Head of Clinical Research Committee/Specialized Lab Supervisor Microbiology
    MD LAB, Dr. Sulaiman AlHabib Medical Group, KSA (September 2023 – Present)

    • Collaborate with scientists and healthcare professionals.
    • Ensure compliance with regulatory agencies (CAP, CBAHI, JCI).
    • Conduct research and write manuscripts for publication.
    • Prepare and present data at international conferences.
    • Facilitate junior researchers and promote clinical research culture through workshops.
    • Train healthcare professionals in study design and scientific writing.
    • Maintain laboratory records and prepare reports.
    • Train and supervise laboratory personnel.
  • Senior Lab Technologist
    Dr. Sulaiman AlHabib Medical Group, KSA (January 2017 – February 2022)

    • Review, revise, and create standard operating protocols for the Clinical Microbiology Lab.
    • Perform laboratory analysis of clinical specimens and interpret results.
    • Monitor accuracy and quality of clinical microbiology testing.
    • Ensure compliance with safety regulations and quality control standards.

Publication top Notes:

Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan

High prevalence of carbapenem-resistant Acinetobacter baumannii associated respiratory tract infections in Pakistani hospitals.

A Cyclic-di-GMP signalling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978

Methylglyoxal: Antimicrobial activity against blood culture isolates of Salmonella Typhi and other Gram negative rods.

In-vitro efficacy of polymyxin B with rifampin, colistin and doxycycline against extensively drug resistant Acinetobacter baumannii

Ashraf Kariminik | Microbiology | Excellence in Research

Published on by Academic Achievements

Dr. Ashraf Kariminik | Microbiology | Excellence in Research

Dr Ashraf Kariminik, Islamic Azad University of Kerman, Iran

Dr. Ashraf Kariminik is an esteemed Associate Professor in the Department of Microbiology at Islamic Azad University, Faculty of Basic Sciences. With a career spanning several decades, he has significantly contributed to the field of microbiology through teaching, research, and active involvement in scientific societies. His research expertise encompasses various aspects of microbial activities, including antibacterial and antifungal properties, as well as environmental microbiology. Dr. Kariminik has also played pivotal roles in organizing and participating in scientific conferences, reflecting his dedication to advancing the field and fostering scientific dialogue.

Profile

Google scholar

Strengths for the Award

  1. Extensive Research Experience:
    • Dr. Kariminik has a long-standing career in teaching and research, spanning several universities. His expertise in microbiology is well-established through numerous research papers and contributions to the field.
  2. High H-index:
    • His H-index of 18 in Google Scholar and 13 in Scopus indicates significant research impact and the high citation count of his work, reflecting its influence and relevance in the scientific community.
  3. Diverse Research Contributions:
    • His research spans various topics including antibacterial and antifungal properties, microbial degradation, and antimicrobial activities. This diversity shows a broad range of expertise and a capacity to contribute to multiple areas within microbiology.
  4. Active Engagement in Scientific Societies:
    • Dr. Kariminik is actively involved in several scientific societies and committees, such as the Iranian Society of Microbiologists and the Iranian Society of Probiotics. His role in organizing and participating in scientific congresses further demonstrates his commitment to advancing the field.
  5. Publication Record:
    • His publication list includes several impactful articles in reputable journals. The breadth of his publications, ranging from antibacterial activities to microbial interactions, underscores his extensive research contributions.

Areas for Improvement

  1. Focus on Emerging Research Areas:
    • While Dr. Kariminik has a wide range of research interests, focusing more on emerging fields within microbiology could enhance his impact. Areas such as synthetic biology, CRISPR technology, and advanced microbial genomics might offer new opportunities for cutting-edge research.
  2. Increased International Collaboration:
    • Expanding his network of international collaborations could further enhance the global reach and influence of his research. Engaging in more international projects and joint publications could improve his visibility and impact on a global scale.
  3. Enhanced Industry Linkages:
    • Strengthening connections with industry and applying research findings to practical, real-world problems could increase the practical impact of his work. Developing partnerships with biotech and pharmaceutical companies could lead to innovative applications of his research.

Education🎓

Dr. Ashraf Kariminik holds a Ph.D., Master’s, and Bachelor’s degrees in Microbiology, all from reputable institutions. He completed his doctoral studies in Microbiology, equipping him with advanced knowledge and research skills. His educational background has provided a solid foundation for his extensive research and academic career, allowing him to make significant contributions to microbiological science and education.

Experience💼

Dr. Kariminik’s academic career includes extensive teaching experience at various campuses of Islamic Azad University, including Kerman, Searjan, and Tehran. He has also contributed to the field through his research roles and active participation in scientific societies such as the Iranian Society of Microbiologists. His professional journey highlights his commitment to both education and research, with a focus on advancing microbiological knowledge and its applications.

Awards and Honors🏆

Dr. Kariminik has received recognition for his research contributions and academic excellence. His high H-index scores on Google Scholar (18) and Scopus (13) underscore his impactful research and citation record. His involvement in organizing international and national microbiology congresses reflects his esteemed position in the scientific community and his dedication to advancing the field of microbiology.

Research Focus🔬

Dr. Kariminik’s research primarily focuses on microbial activities, including antibacterial and antifungal properties, microbial degradation of pollutants, and the role of probiotics. He investigates the antimicrobial properties of medicinal plants and the application of nanoparticles in microbial control. His research aims to address practical challenges in microbiology and contribute to environmental and health-related solutions.

Publication Top Notes

Antibacterial and antifungal survey in plants used in indigenous herbal-medicine of south east regions of Iran 🌿🦠

Streptomycetes: characteristics and their antimicrobial activities 🦠🔬

Pseudomonas aeruginosa quorum sensing modulates immune responses: an updated review article 🦠🔍

Isolation and characterization of alkane degrading bacteria from petroleum reservoir waste water in Iran 🛢️🦠

Biological control of Sclerotinia sclerotiorum, causal agent of sunflower head and stem rot disease, by use of soil borne actinomycetes isolates 🌻🦠

Simultaneous determination of phenylhydrazine, hydrazine and sulfite using a modified carbon nanotube paste electrode ⚛️🧪

Hexadecane-degradation by Teskumurella and Stenotrophomonas strains isolated from hydrocarbon contaminated soils 🌍🦠

Antibacterial activity of some medicinal plants of Iran against Pseudomonas aeruginosa and P. fluorescens 🌿🦠

Antimicrobial activity of different parts of Phoenix dactylifera 🌴🦠

In vitro evaluation of antibacterial properties of zinc oxide nanoparticles on pathogenic prokaryotes ⚛️🦠

Conclusion

Dr. Ashraf Kariminik is a highly qualified candidate for the Research Excellence Award. His substantial research experience, high H-index, active involvement in scientific communities, and diverse publication record highlight his significant contributions to the field of microbiology. By focusing on emerging research areas, fostering international collaborations, and enhancing industry linkages, he could further elevate his impact and continue to contribute meaningfully to scientific advancement.